All Stories

  1. Antibiotic use and the efficacy of immune checkpoint inhibitors in cancer patients: a pooled analysis of 2740 cancer patients
  2. Circulating Noncoding RNAs Have a Promising Future Acting as Novel Biomarkers for Colorectal Cancer
  3. Statin use and its potential therapeutic role in esophageal cancer: a systematic review and meta-analysis
  4. Preoperative Anemia or Low Hemoglobin Predicts Poor Prognosis in Gastric Cancer Patients: A Meta-Analysis
  5. Palliative gastrectomy plus chemotherapy versus chemotherapy alone for incurable advanced gastric cancer: a meta-analysis
  6. Do Patients with Second Primary Colorectal Cancer Hold the Similar Prognosis and Therapeutic Benefits as Those with Initial Primary Colorectal Cancer?
  7. Can Preoperative Examination Help Choose the Best Surgical Procedure in Gastric Cancer?
  8. The Differential Expression of Core Genes in Nucleotide Excision Repair Pathway Indicates Colorectal Carcinogenesis and Prognosis
  9. Current issues of preoperative radio(chemo)therapy and its future evolution in locally advanced rectal cancer
  10. Mechanism of immune evasion in breast cancer
  11. RANKL/RANK pathway abrogates cetuximab sensitivity in gastric cancer cells via activation of EGFR and c-Src
  12. High Platelet-to-Lymphocyte Ratio Predicts Poor Prognosis and Clinicopathological Characteristics in Patients with Breast Cancer: A Meta-Analysis
  13. Efficacy and safety of anti-epidermal growth factor receptor therapy compared with anti-vascular endothelial growth factor therapy for metastatic colorectal cancer in first-line and second-line therapies: a meta-analysis
  14. Clinicopathological significance of claudin 4 expression in gastric carcinoma: a systematic review and meta-analysis
  15. Long noncoding RNAs in gastric cancer: functions and clinical applications
  16. Upregulated long intergenic noncoding RNA KRT18P55 acts as a novel biomarker for the progression of intestinal-type gastric cancer
  17. Association between promoter polymorphisms of OPN gene and cancer risk: a meta-analysis
  18. The Efficacy and Toxicity of Paclitaxel Plus S-1 Compared With Paclitaxel Plus 5-Fu for Advanced Gastric Cancer
  19. Clinical significance of promoter region hypermethylation of microRNA-148a in gastrointestinal cancers